Abstract:Avian infectious bronchitis virus (IBV) is the causative agent of infectious bronchitis, which results in considerable economic losses. It is imperative to develop safe and efficient candidate vaccines to control IBV infection. In the current study, recombinant baculoviruses co-expressing the S1 and N proteins and mono-expressing S1 or N proteins of the GX-YL5 strain of IBV were constructed and prepared into subunit vaccines rHBM-S1-N, rHBM-S1 and rHBM-N. The levels of immune protection of these subunit vaccines were evaluated by inoculating specific pathogen-free (SPF) chickens at 14 days of age, giving them a booster with the same dose 14 days later and challenging them with a virulent GX-YL5 strain of IBV 14 days post-booster (dpb). The commercial vaccine strain H120 was used as a control. The IBV-specific antibody levels, as well as the percentages of CD4+ and CD8+ T lymphocytes, were detected within 28 days post-vaccination (dpv). The morbidity, mortality and re-isolation of the virus from the tracheas and kidneys of challenged birds were evaluated at five days post-challenge (dpc). The results showed that the IBV-specific antibody levels and the percentages of CD4+ and CD8+ T lymphocytes were higher in the rHBM-S1-N vaccinated birds compared to birds vaccinated with the rHBM-S1 and rHBM-N vaccines. At 5 dpc, the mortality, morbidity and virus re-isolation rate of the birds vaccinated with the rHBM-S1-N vaccine were slightly higher than those vaccinated with the H120 control vaccine but were lower than those vaccinated with the rHBM-S1 and rHBM-N vaccines. The present study demonstrated that the protection of the recombinant baculovirus co-expressing S1 and N proteins was better than that of recombinant baculoviruses mono-expressing the S1 or N protein. Thus, the recombinant baculovirus co-expressing S1 and N proteins could serve as a potential IBV vaccine and this demonstrates that the bivalent subunit vaccine including the S1 and N proteins might be a strategy for the development of an IBV subunit vaccine.

Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus.

Construction And Immunogenicity Of Novel Chimeric Virus-Like Particles Bearing Antigens Of Infectious Bronchitis Virus And Newcastle Disease Virus

Lactococcus Lactisanchoring Avian Infectious Bronchitis Virus Multi-Epitope Peptide EpiC Induced Specific Immune Responses in Chickens

Construction and Immunogenicity Comparison of Three Virus-Like Particles Carrying Different Combinations of Structural Proteins of Avian Coronavirus Infectious Bronchitis Virus.

Assembly and Immunogenicity of Baculovirus-Derived Infectious Bronchitis Virus–like Particles Carrying Membrane, Envelope and the Recombinant Spike Proteins

A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals

Chimeric Influenza-Virus-like Particles Containing the Porcine Reproductive and Respiratory Syndrome Virus GP5 Protein and the Influenza Virus HA and M1 Proteins.

Preparation of ChIL-2 and IBDV VP2 Fusion Protein by Baculovirus Expression System

Production and Immunogenicity of Chimeric Virus-Like Particles Containing Porcine Reproductive and Respiratory Syndrome Virus GP5 Protein

Assembly and Immunological Properties of a Bivalent Virus-Like Particle (VLP) for Avian Influenza and Newcastle Disease

Efficacy of a plant-produced infectious bronchitis virus-like particle vaccine in specific pathogen-free chickens

Development and Immunoprotection of Bacterium-like Particle Vaccine Against Infectious Bronchitis in Chickens.

Immunogenicity and Protective Efficacy of Recombinant Fusion Proteins Containing Spike Protein of Infectious Bronchitis Virus and Hemagglutinin of H3N2 Influenza Virus in Chickens.

Protective effects of a novel chimeric virus–like particle vaccine against virulent NDV and IBDV challenge

Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins

Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV

Protection efficacy of the H1 and H3 bivalent virus-like particle vaccine against swine influenza virus infection

A Self-Adjuvanted Nanoparticle Based Vaccine Against Infectious Bronchitis Virus

Protection Against Virulent Infectious Bronchitis Virus Challenge Conferred By A Recombinant Baculovirus Co-Expressing S1 And N Proteins

Efficient Production and Characterization of Immunogenic HEV-PCV2 Chimeric Virus-Like Particles

Broadly cross-reactive immune responses in chickens immunized with chimeric virus-like particles of nodavirus displaying the M2e originated from avian and human influenza A viruses